Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing coronary artery disease using CT angiography

Official title: Comprehensive Anatomical and Physiological Evaluation of Patients With Stable Coronary Artery Disease.

Run by CoreAalst BV · NCT06205810 · Data updated 2026-11-12

This study is testing how well a special heart scan called CT angiography can measure heart artery blockages in patients who need further heart tests.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorCoreAalst BV
Industry-sponsored
Locations1 site (Aalst, Oost-Vlaanderen)
StatusRecruiting
StartedOctober 24, 2023
Main results expectedOctober 15, 2030
Study endsOctober 15, 2031
Registry record updatedJanuary 20, 2026
Trial IDNCT06205810 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with epicardial stenosis greater than 50% who are indicated for invasive coronary angiography.

Probably not a fit

Patients with conditions such as STEMI, severe arrhythmias, or significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The COMPLETE study is an observational study focusing on patients who require invasive coronary angiography after undergoing coronary CT angiography (CCTA). It aims to evaluate the accuracy of CCTA in quantifying total atheroma volume, using intravascular ultrasound as a reference standard. Participants will be divided into two cohorts: those with stable coronary artery disease or stabilized acute coronary syndromes, and those previously revascularized with a metallic stent. Eligible patients must have significant epicardial stenosis identified through CCTA.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic accuracy for coronary artery disease, leading to better patient management and outcomes.

How similar studies have gone: Other studies have shown promising results in using CCTA for coronary artery disease assessment, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\. Epicardial stenosis more than 50% by visual assessment.

Exclusion Criteria:

1. STEMI.
2. Hemodynamic instability.
3. Rapid atrial fibrillation, flutter or arrhythmia (HR \> 80 bpm).
4. Insufficient CCTA image quality.
5. Age \<18 years.
6. Chronic obstructive pulmonary disease.
7. Contraindication to adenosine.
8. NYHA class III or IV, or last known left ventricular ejection fraction \<30%.
9. Uncontrolled or recurrent ventricular tachycardia.
10. History of recent stroke (≤90 days).
11. Prior myocardial infarction.
12. History of ischemic stroke (\>90 days) with modified RANKIN score ≥ 2.
13. History of any hemorrhagic stroke.
14. Previous coronary artery bypass surgery.
15. Active liver disease or hepatic dysfunction, defined as AST or ALT \> 3 times the ULN.
16. Severe renal dysfunction, defined as an eGFR \<30 mL/min/1.73 m2.
17. BMI \>35 kg/m2.
18. Nitrate intolerance
19. Contra-indication to heart rate lowering drugs.
20. Unable to provide written informed consent.

Where it's running

  • OLV Hospital Aalst
    Aalst, Oost-Vlaanderen, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.